Minna Blomster joins HippocrAItes - "I want to promote patient-centered healthcare."

Minna Blomster joins as Business Development Director at HippocrAItes. She is a strategic and creative growth expert with strong expertise in the pharmaceutical industry, social and healthcare sectors, and healthcare digitalization.

Minna has a long and impressive career in the pharmaceutical and healthcare industries, including roles at AstraZeneca, FINBB, Varha, and Hibox. "We are excited to have such a highly skilled professional join our team. Minna will strengthen the very areas we need to bring the Hippo Health Platform into the daily lives of individuals and professionals," says Juuso Haavisto, CEO of HippocrAItes.

Towards personalized health with Hippo

Minna's extensive experience in leading healthcare digitalization and go-to-market strategies, along with her expertise in the health technology market, utilization of health data, and regulation, supports HippocrAItes' next growth phase, which is the commercialization of the Hippo Health Platform in 2025.

In her international career, Minna has developed solutions that improve patient care, accelerate the utilization of research data, and support strategic growth. "Hippo is not just technology – it's a change in mindset. I see tremendous potential in HippocrAItes to transform the healthcare service pathway through data and AI, enabling a personalized care model for both the public and private sectors in a completely new way," Minna says.

Minna will be joining HippocrAItes' Future Health seminar at Villa Salin on Tuesday, April 29, 2025.